why choose us

First received: June 30, 2023

Clinical Trial: Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Glioma

Study Type: OBSERVATIONAL


Official Title: Development of Activity MRI (aMRI): Direct Comparison to PET in Human Subjects

Brief Summary: This is an observational study to compare the utility of the novel aMRI approach in human brain to the standard of care imaging approach for diagnosing and assessing glioma.Tumor cells have altered metabolism compared to normal cells.This makes metabolic activity imaging useful for diagnosing and assessing neurological disease.However, current options for metabolic activity imaging are limited.Metabolic activity imaging is primarily conducted using positron emission tomography (PET) with a radioactive tracer…

Read more